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 urpose: This review encompasses several practical comP
ponents of supervised exercise therapy (SET) for patients
with claudication including referral, exercise training, and
billing issues. Real-life SET session examples are also provided. SET was approved for reimbursement by the Centers for Medicare & Medicaid Services (CMS) in 2017, and
there is continual growth of programs offering SET and in
participation. The purpose of this review is to provide useful information for the clinical exercise professionals working with these patients.
Review Methods: The 2016 ACC/AHA Guideline on the
Management of Patients With Lower Extremity Peripheral Artery
Disease (PAD) provided a class I (highest level) recommendation
for the use of SET in those with symptomatic PAD. Since there
has been much growth in the literature about the utility of SET,
the literature was reviewed (PubMed) to provide information
for this article. Topics reviewed include the benefits of exercise
training, exercise prescription, billing, referral and participation,
and best practices.
Summary: SET should be offered to all patients with
symptomatic PAD who are not at risk of acute limb ischemia.
For optimal results, SET should be implemented several times
per week and in a progressive process to increase exercise
intensity as tolerated. For best results, programs should
recommend patients supplement SET with home exercise.
Considerations for utilizing reimbursed sessions should also
be discussed because patients have a maximum of 72 sessions/
lifetime. Referral practices need refinement, and participation
rates remain extremely low and may be influenced by
demographics. Research on best practices and home or hybrid
training must continue to address issues related to common
enrollment and participation barriers.
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KEY PERSPECTIVES
• This article summarizes contemporary key items
necessary to understand when developing and implementing a supervised exercise therapy (SET) program for those with symptomatic peripheral artery
disease.
• Clinical exercise program staff should familiarize
themselves with all aspects of SET, which
include patient recruitment and selection, SET
implementation and progression, and insurance and
billing information.

I

t is well established by numerous randomized controlled
trials that regular structured exercise therapy improves the
walking performance of those with symptomatic peripheral
artery disease (PAD).1 Furthermore, evidence is accumulating that performing supervised exercise therapy (SET) following revascularization for claudication will more likely
lead to maximal functional benefits versus revascularization
or SET alone.2,3 In May 2017, the Centers for Medicare
& Medicaid Services (CMS) in the United States approved
coverage of SET for beneficiaries with intermittent claudication. Supervised exercise therapy is considered the gold
standard for improvement in walking performance and
is a class IA recommendation in the current ACC/AHA
Guideline for the treatment of PAD.4 The CMS Decision
Memo allows for SET to be implemented in either a clinical/
physician office or in a hospital outpatient setting (ie, cardiac rehabilitation [CR] environment).5
Currently, little is known about the implementation of
SET in the United States. Dua et al6 gathered information
by survey regarding availability, awareness, and utilization
of SET in the United States. Of the 900 vascular surgeons,
medicine physicians, and cardiologists who were sent the
survey (8 questions), 135 (15%) responded. Of these, 54%
stated that they did not have a program at their hospital
facility and 5% did not know whether a program existed.
Those with a program available were overwhelmingly in
the CR setting (81%). When asked about referring a patient to a SET program, 98% stated that they would refer
a patient; however, only 49% stated that they had referred.
Seventy-four percent of respondents were aware of CMS
coverage for SET, but only 39% of these stated that they
had referred. These data demonstrate that both referral to
and access of programs are barriers. This article provides
practical information about the implementation of SET, focusing on aerobic exercise training, in those with symptomatic PAD, along with information about billing practices
and utilization.
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AEROBIC EXERCISE MODES AND
PRESCRIPTION FOR SET
Peripheral artery disease is caused by atherosclerotic lesions and obstructions in the arteries of the lower extremities, which reduces blood flow to the leg musculature and
causes a mismatch between oxygen supply and metabolic
demands of the muscle during exercise.7 In mild PAD, this
mismatch does not result in symptoms, but as PAD becomes
more severe, patients experience leg pain during walking,
called “claudication,” which leads to a sedentary lifestyle.8
Exercise sessions during SET cause the mismatch between
oxygen supply and muscle metabolic demands to occur, resulting in claudication, which eventually forces patients to
stop walking and rest. During the rest period, ischemia in
the leg musculature dissipates and pain resolves, which enables a subsequent walking bout to be initiated free of pain.
Intermittent walking done chronically causes vascular and
muscular adaptations in the legs that lead to improvements
in walking distances typically observed with SET.9,10 These
adaptations are not well understood, but numerous mechanisms have been proposed to explain the improvement in
walking distances.11 Potential mechanisms include improved
endothelium-dependent vasodilation,12 increased capillary
density of the gastrocnemius muscle,13 improved skeletal
muscle metabolism,14 reduced levels of inflammatory biomarkers,15 improved walking economy,16 and improved aerobic capacity.11 Improved walking distances may enable patients with PAD to walk more during each day at moderate
intensity, which is associated with better vascular function,17
and which may increase the likelihood of meeting physical
activity time-intensity guidelines recommended for adults.18
To better ensure that a program of SET improves walking
distances, several key factors need to be considered related
to the mode of exercise and the exercise prescription.
The goal of SET for patients with PAD is to improve
walking performance. Most studies have demonstrated
the efficacy of intermittent treadmill walking exercise in
patients with PAD.19 The traditional exercise prescription
includes intermittent treadmill walking and is reviewed
in Figure 1. Table 1 provides the pain/discomfort scale.
This training pattern should be continued throughout the
12 wk/36 sessions of a SET program.
Although the typical mode of exercise during the SET
program is treadmill exercise, alternative modes of exercise may be utilized.4,8 These can include aerobic arm exercise20-22 and total body recumbent stepping,23 which are effective in improving walking performance in these patients.

Table 1
Pain/Discomfort Scale for Exercise Traininga
0: No pain
1: Initial pain/discomfort, very mild
2: Mild pain/discomfort
3: Moderate pain/discomfort
4: Severe pain/discomfort
a

Careful use of the pain/discomfort scale is important. All patients should be anchored to
what “no pain” and “severe pain” feel like. This will improve the likelihood that a patient
can recognize when he or she is at the “mild” or “moderate” pain/discomfort levels. Some
guidelines refer to level 3 as moderately severe pain/discomfort.

These alternative modes may be particularly appropriate
for patients who are not able to safely walk on a treadmill, those who do not progress appropriately, and those
with more severe disease who can perform only treadmill
walking for short periods of time, which limits the exercise
duration required to gain benefit.
It is recommended that the initial exercise prescription begin with intermittent treadmill walking and then
switch to another mode if needed for safety, or if the
patient does not progress after performing several sessions of treadmill exercise. Examples are provided in
case format later in this article. If patients who perform
these alternative modes of exercise experience ischemic
leg symptoms (ie, pain/discomfort of claudication), progression would mirror that of treadmill exercise. If no
pain/discomfort is experienced, progression of the exercise prescription would be based on rating of perceived
exertion and target heart rate.10
For the first SET session, the exercise professional should
have specific objectives as described previously.10 Namely,
the most appropriate exercise training modality for each
patient should be determined, followed by selecting an appropriate exercise intensity to perform, and educating the
patient about the planned progression of the SET sessions
in terms of increases in duration and intensity of exercise.
The SET sessions should be performed according to the
appropriate individualized exercise prescription for each
patient regarding the intensity, session duration, frequency,
claudication intensity, work-to-rest ratio, and the planned
progression of the program as shown in the Table 2. Also
refer to Figure 1 and Table 1 for information on progression and the pain/discomfort scale.

Figure 1. Progressive treadmill walking training program example for supervised exercise therapy (SET) in those with symptomatic peripheral artery
disease. Each arrow provides information about decisions to be made for individual patient participating in SET. This figure is available in color online
(www.jcrpjournal.com).
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Table 2
Exercise Prescription for Training Patients With Peripheral Artery Disease With Claudicationa
Variable

a

Recommendation

Ideal modality

Supervised treadmill walking

Intensity

40-60% maximal workload based on baseline treadmill test

Session duration

Begin with 30-50 min intermittent exercise with the goal of accumulating 30-50 min of total walking exercise

Maximum claudication intensity

Mild to moderate pain/discomfort (see Table 1)

Work-to-rest ratio

Ideally walking duration should be between 5 and10 min. If mild/moderate pain/discomfort occurs earlier than 5 min, then
intensity should be reduced. If later than 10 min, then intensity should be increased. Walking bouts are followed by rest until
pain/discomfort has dissipated (often in 2-5 min)

Frequency

3 times/wk supervised; supplemented with home walking

Program duration

≥12 wk and 36 sessions; consider more sessions as indicated by individual patient

Progression

Every 1-2 wk or greater: increase duration of training session to achieve 50 min (see Figure 1)

Maintenance

Lifelong maintenance ≥2 times/wk, but preferably 6-7 times/wk

Adapted from Treat-Jacobson et al.10

EXERCISE TRAINING LOCATION: CLINIC
VERSUS COMMUNITY SETTINGS
RATIONALE FOR CONSIDERING COMBINING SET
AND HOME-BASED EXERCISE SESSIONS
During the initial SET program, a total of 36 exercise sessions are covered during a 12-wk period by CMS and most
commercial insurers.10 Following this initial training program, an additional 36 SET sessions can be requested if the
patient continues to have lower extremity ischemic symptoms. The CMS coverage policy does not specify a time
frame for completion of these additional 36 sessions, which
yield a total of 72 lifetime exercise sessions. However, interpretation is at the discretion of the Medicare Administrative
Contractor of each state. These exercise sessions need to be
completed in a supervised setting, such as a hospital outpatient setting. They cannot be completed at home. However, home exercise training may be advantageous for some
patients as either an adjunct to, or in place of, SET in a
hospital or clinic setting.
In addition, although a SET program is highly efficacious
to improve walking ability, overall functional status, and
health-related quality of life,9 >36-72 exercise sessions are
needed for continued lifetime ambulatory and health benefits, as well as to lower risks of all-cause mortality, cardiovascular mortality, and cardiovascular events.24-26 For these
reasons, it is important to implement home-based exercise
sessions on a long-term basis both during and once the allotment of SET sessions is completed.
PRACTICAL ASPECTS FOR COMBINING SET AND
HOME-BASED EXERCISE SESSIONS
During the initial 12-wk program, three SET sessions and
more should be performed each week, with a goal of two
additional home-based exercise sessions and more included
in the weekly exercise prescription to provide an adequate
volume of weekly exercise. Given that these exercise sessions will be performed at a moderate intensity or above,
the combination of the SET and home-based sessions will
enable patients to meet the 2018 aerobic Physical Activity
Guidelines for Americans by performing 150-300 min/wk
of moderate-intensity aerobic activity.27
In addition, another advantage of combining SET sessions with home-based exercise is that patients learn to
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incorporate exercise into their lifestyle. This aspect becomes increasingly important if patients transition from
the 12-wk/36 visit program to an additional 36 SET sessions afterward. As an example, one approach to this
phase might be completing one SET session/wk for 36 wk,
supplemented with four home-based exercise sessions/wk.
The SET sessions could be interspersed >1 wk apart to
lengthen the total time of utilizing all the additional 36
SET sessions, if desired. In this manner, a similar weekly
volume of exercise can be completed during the long-term
phase compared with the initial 12-wk phase of the program, and supervised SET sessions can occur continuously
for ≥48 sessions/wk.
It is important that home-based exercise sessions match
SET sessions as closely as possible.28 Fortunately, with the
availability of many physical activity–monitoring devices
for patients to wear during each home-based exercise
session, the ability to confirm adherence to completing
exercise sessions as well as to quantify the duration and
intensity of the exercise sessions is possible. The exercise
prescription for each home-based exercise session should
be similar to the SET program, specifically regarding intensity, session duration, claudication intensity to reach
during exercise, the work-to-rest ratio, and finally modifications made to achieve the appropriate progression
throughout the program.
Because a Medicare-insured patient is limited to 72 SET
sessions during their lifetime, consideration for each individual patient should be made regarding whether to use all
those sessions at once, or to save them if the patient requires
SET in the future. One avenue of thought is to use them all
at the initial referral so that patients can maximize their
improvement and potentially learn to exercise long-term.
In addition, there is no guarantee that a patient will ever
be able to use remaining sessions in the future because of
financial or health situations. Another avenue of thought
is to save the sessions. An example would be to discharge
patients from SET once they have demonstrated sufficient
improvement (to be defined by the patients) and are able to
independently exercise. Another example might be to transfer to a maintenance program (eg, phase 3) to save SET
sessions. This latter suggestion, in most cases, would be a
less expensive out-of-pocket cost for the patient (eg, SET
session copay ∼$11.50 vs typical maintenance program
cost of $50–60/mo).
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EXAMPLES OF THE PAD PATIENT IN
“REAL-LIFE” SET
The clinical exercise professional is regularly presented
with several challenges over the course of a SET program.
Often, the first and most challenging aspects are establishing the proper initial exercise prescription and the overall
evaluation of the initial SET sessions. The exercise goals of
the first two SET sessions are to (1) establish the primary
exercise modality to be used during the SET program, and
(2) determine the proper intensity where mild to moderate
pain/discomfort (2-3/4) (Table 1) develops within 5-10 min
of exercise for modalities that induce pain/discomfort.20,29
In addition, it is important for the clinical exercise professional to be watchful for the following: prolonged rest
intervals during interval exercise and a lack of improvement in walking performance. Awareness of these and other
exercise-related factors is important for a successful SET
program. The following real-life cases provide examples.
EXAMPLE 1: APPROPRIATE USE OF MULTIMODAL
AEROBIC EXERCISE
Following the first two SET sessions, it is essential for the
clinical exercise professional to review the exercise logs to
determine the primary exercise modality in subsequent SET
sessions. To accomplish this, attention should be focused
on absolute exercise intensity (metabolic equivalent task
[METs]), durations of exercise and rest bouts, and total exercise time. For instance, if an individual performs treadmill
exercise and has a pattern of low intensity (ie, <2.5 METs)
and short walking bouts (<5 min), it is important to prescribe multimodal aerobic exercise instead of treadmill exercise alone.29 Supplemental Digital Content 1, available at:
http://links.lww.com/JCRP/A412, illustrates this point. In
the first SET session, the patient had short walking bouts,
a low absolute exercise intensity, and a short total walking
time. In the second session, following a second short- and
light-intensity walking bout, the exercise modality was
switched to total body recumbent stepping, which resulted in exercise bout durations approximately 5- to 10-fold
longer than treadmill walking at a similar MET level. This
patient performed multimodal aerobic exercise for the remaining SET sessions. This approach can also be useful to
maximize the dose of exercise accumulated over the course
of the SET program.23,29
EXAMPLE 2: ESTABLISHING THE CORRECT
INTENSITY FOR EXERCISE MODALITIES THAT
INDUCE CLAUDICATION
Determining the intensity that produces mild to moderate (2-3/4 rating; see Table 1) pain/discomfort during
walking (or other exercise) within 5-10 min requires
both a review of the exercise history of the patient and a
trial-and-error approach.29 Supplemental Digital Content
2, available at: http://links.lww.com/JCRP/A412, illustrates trial-and-error approach to establish the appropriate exercise intensity that induces pain/discomfort. In
this example, workloads for both patients 1 and 2 were
inappropriately adjusted throughout the session. Exercise
intensity should have been decreased for walking bouts 2
and 3 for patient 1 and increased for patient 2. Patient
3 depicts an appropriate trial and error to inducing mild
to moderate pain/discomfort within 5-10 min of walking.
In this trial-and-error approach, the initial comfortable
walking speed chosen by the patient (1.8 mph) induced
mild to moderate pain/discomfort in <5 min. Since there
is no specific guidance for adjusting the intensity to target

5- to 10-min walking bouts, the clinical exercise professional decided to reduce the intensity by roughly 20% (0.4
mph) in that the next walking bout was performed at 1.4
mph. This change resulted in a walking time >10 min in
the second walking bout. Therefore, for the third walking
bout, the clinical exercise professional decided to use the
average speed of walking first and second walking bouts
(1.6 mph) in the third walking bout. This approach yielded
a walking bout that produced moderate pain/discomfort
within 5-10 min of walking and was used as their baseline
exercise prescription.
EXAMPLE 3: PROLONGED REST PERIODS
Careful consideration of the length of rest intervals, particularly in the initial several SET sessions, can help achieve a
maximal dose of exercise. The typical amount of time for
pain/discomfort to dissipate following exercise to mild to
moderate pain ranges between 2 and 5 min and may depend
on patient perception of pain, disease severity, pain severity
during exercise, and method of rest (eg, sitting vs standing). In
Supplemental Digital Content 3, available at: http://links.lww.
com/JCRP/A412, the rest intervals were 8-9 min throughout
the SET sessions. During SET, this patient performed three
walking bouts/session. If rest intervals were reduced to 5 min,
the total session time would shorten by approximately 9-12
min. This time savings would allow one more walking bout/
session to occur, thereby increasing the total exercise dose. At
the lowest MET level of walking during SET for this patient
(ie, session 1 = 2.8 METs), one additional 9-min walking
bout could be performed each session, which accumulates to
an additional 907 MET-min of exercise over 36 sessions. In
this example, the patient may not have been paying close attention to pain dissipation, and staff monitoring may be successful in shortening the rest intervals.
EXAMPLE 4: “I DON’T THINK MY WALKING IS
GETTING BETTER” VERSUS “THE TRUE
NON-RESPONDER”
It is not unusual for patients to become frustrated with progress during SET, particularly during interval exercise. Patients
may focus on the lack of increase in bout (interval) duration
and may not recognize that progression in exercise intensity
is designed to keep bout durations within 5-10 min. In this
event, the clinical exercise professional should listen to the
patient concerns and utilize the exercise logs to demonstrate
potential changes in exercise intensity that the patient may
have not considered. Alternatively, repeating the exercise
prescription of the first SET session is an excellent practical
method to demonstrate improvement in walking bout duration. This is demonstrated in Supplemental Digital Content
4, available at: http://links.lww.com/JCRP/A412 (depicts exercise logs accumulated for several selected sessions) where
Patient A walked for 8:15 min during the first walking bout
of their first SET session (2.0 mph and 1%). By session 12,
Patient A still had walking bouts 6-8 min in duration but
had progressed to 2.0 mph and 4%. Despite the change in
METs over the first 12 sessions evident upon review of the
training logs, Patient A voiced there was no improvement in
walking performance. In response the clinical exercise professional repeated session 1 intensity (2.0 mph and 1%) at
the beginning of the 13th session to compare for potential
walking improvements. At this intensity Patient A walked
for 12:30 min before moderate claudication was experienced
which represented a 4:15 min improvement and made clear
to the patient that there was improvement.
An example of lack of improvement is depicted for
patient B where a review of the exercise logs showed no
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change in total exercise time and intensity (METs). As for
patient A, the first walking bout of session 1 was repeated
at the beginning of the 13th session. However, in the case of
patient B, there was only a 22-sec improvement in walking
time to mild to moderate pain when repeating the session 1
exercise prescription. As a result, the exercise prescription
of patient B was switched from a treadmill only modality to
multimodal aerobic exercise including both treadmill and
total body recumbent stepping. This is a suggested practice
in those showing little improvement during walking.10
MISINTERPRETATION OF THE EXERCISE
PRESCRIPTION FOR INTERVAL TRAINING
MODALITIES
Finally, it is important for the clinical exercise professional
to closely review the duration of exercise bouts recorded in
patient exercise logs, particularly in patients allowed to independently determine when to stop walking, and intensity
progression. When performing exercise that induces pain,
it is a common misinterpretation by the patient to exercise
for a specific bout duration and not into mild to moderate
pain. Since the goal in this type of exercise is to induce mild
to moderate pain/discomfort within 5-10 min, look for exercise logs that are continuously displaying bout durations
of 5 or 10 min.

PAYMENT AND REIMBURSEMENT
Although most insurance carriers now consider SET for
those with symptomatic PAD to be a reimbursable service,
there are questions, issues, and concerns relative to coverage determinations, out-of-pocket expenses, and potential
for low adherence and nonparticipation. This section reviews the general reimbursement rules and provides other
payment information.
As stated, CMS reimburses for SET services for Medicare beneficiaries with symptomatic PAD. Well-established
evidence for the benefit of SET with this population led to
the CMS coverage policy in 2017.5 Through this policy,
SET is recommended as the initial treatment for patients
with claudication, and Medicare beneficiaries are eligible
to participate in SET if claudication is present. Notably,
there are no ankle-brachial index (ABI), disease burden,
or other qualifying criteria required for eligibility. Patients who have had a recent surgical intervention, such
as a stent, continue to be eligible for SET if symptoms of
claudication are still present.
The Medicare regulation is the National Coverage Determination (NCD) 20.35 (5-25-2017), Supervised Exercise Therapy for Symptomatic Peripheral Artery Disease.
Within this document, the following expectations are outlined for the physician referral of an eligible patient to a
SET program:
• The patient must have a face-to-face visit with the physician to obtain a referral to SET.
• The patient must receive information at the office visit
regarding PAD risk factor reduction and cardiovascular
disease; this may include education, counseling, behavioral interventions, and outcome assessments.
The NCD also outlines requirements specifically for the
SET program, which have been provided elsewhere in this
document.
Although SET can be provided in a CR program setting,
by the same staff, and concurrent with a CR session, it is
important to recognize that SET is a separate service from
CR. Each program (CR and SET) has a distinct coverage
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provision. For example, CR requires a monthly individualized treatment plan (ITP) with exercise, educational, and
assessment components. Supervised exercise therapy does
not require this. As noted previously, education/counseling
for PAD is the responsibility of the referring physician. Although both CR and SET services may be delivered concurrently and in the same space with the same qualified staff,
it would not be clinically logical for a patient to receive CR
and SET at the same time. Clinical need should determine
which treatment takes precedence. It would be clinically appropriate for a patient with qualifying diagnoses for both
CR and for SET to enroll in and complete one program
(typically CR) and then follow with SET if CR training did
not resolve claudication and symptoms continue to justify
a course of SET.
Another stipulation in the SET NCD that merits clarification is that Medicare Administrative Contractors have
the discretion to cover SET beyond 36 sessions over 12 wk
and may cover up to an additional 36 sessions with a new
referral order, but not exceeding 72 sessions, over an extended period. Keep the points in Table 3 in mind when
interpreting coverage by Medicare.
There is one procedure code (CPT 93668) available for
SET services, which may be used one time/d.31 There is no
requirement or restriction on the number of d/wk SET may
be provided to a Medicare beneficiary. An inclusive list of
eligible International Classification of Diseases, Tenth Revision (ICD-10) codes can be found in published Medicare
regulations for SET.31
A major barrier to adherence to a SET program is Medicare and Medicare Advantage plan copayments. These patient costs are incurred per session and are in the range of
$11 to $12. For beneficiaries with a lower socioeconomic
status, and others, it is a deterrent to completion. Research
indicates a higher prevalence of PAD in this subset of patients, possibly due to an increased prevalence of cardiovascular risk factors and poor access to health care.32

REFERRAL PROCESSES AND PROGRAM BEST
PRACTICES
Divakaran et al33 published a paper assessing SET PAD
referral and participation since CMS coverage approval.
They assessed Medicare data from June 1, 2017, through
December 31, 2018, representing the initial 18 mo of coverage. In that period, there were 129 699 individuals identified with a claudication diagnosis based on ICD-10 coding.
Of these, only 1735 (1.3%) enrolled in a SET program and
had ≥1 billable session. And of these, the median sessions
performed was 16 (IQR: 6-28), and only 89 (5.1% of those
enrolled) completed the full allotment of 36 sessions. Those
who enrolled (vs not enrolled) were slightly older (74 ± 8
vs 73 ± 9 yr; P = .02), more likely to be White (87% vs
84%), less likely to be Black (9% vs 11%) and female (39%
vs 43%), and less likely to be dually enrolled in Medicaid
(13% vs 22%). Most enrollees were from the Midwest
(48%) and Northeast (16%) regions of the United States.
These data suggest that age, race, sex, and socioeconomic
status may play a role in enrollment to SET. A possible limitation of this early data is a low availability of programs
providing SET. Although this remains a barrier to participation, there has been an increase in locations offering SET
across the United States.
Using CMS data for 2020, 30 945 claims were submitted
to CMS for SET through November 23, 2020.34 Using the
median number of sessions performed (ie, 16) this suggests
that more than 1900 patients attended ≥1 session of SET.

Practice-Based Recommendations for SET PAD    5
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Table 3
Considerations for Interpreting Insurance Coveragea
• CMS limits SET to a maximum of 72 sessions in the “Medicare lifetime” of a beneficiary.
• CMS uses the HIPAA Eligibility Transaction System (HETS) software to track Medicare services that are capped. SET for PAD and pulmonary rehabilitation are two
examples of such services.
• HETS initially displays 72 SET sessions on provider query screens for all Medicare beneficiaries. Hospital billing departments have access to this information.
• As sessions are used, HETS displays the remaining number of SET sessions left. There can be a 1- to 2-mo lag in the accuracy of the HETS sessions count.
• When 72 SET sessions have been delivered, any further claims to FFS Medicare will be denied, with or without a qualifying diagnosis for SET.
• Medicare Advantage Organizations (MAOs) process and pay their own claims. It is plan-specific whether the KX modifier rule is followed and whether the total
number of sessions in the “Medicare lifetime” of a beneficiary is limited.
• It is suggested to ask each patient whether he or she has had SET sessions previously for his or her PAD. If they respond “yes,” it is recommended to investigate
how many sessions are remaining using HETS. A hospital or clinic billing office should be able to determine this information.
• It is at the MAC discretion, retroactively, whether more sessions will be reimbursed beyond the “up-to-36 session” course or beyond the 12-wk time frame (ie,
extra 36 visits over 24 or 36 wk).
 A second referral is required for these additional sessions.5
 
The inclusion of a KX modifier on the claim is attestation by the provider of the services that documentation is on file verifying that further treatment beyond
the 36 sessions and/or over 12 wk meets the requirements of the medical policy.30
 Retroactive claims that are denied by the MAC are the financial responsibility of
 the beneficiary if an ABN was signed, or
 the institution if an ABN was not obtained.
• Various commercial insurances will have their own coverage conditions.
• For commercial payors, consider performing a “coverage determination” before enrolling a patient in SET.
Abbreviations: ABN, advanced beneficiary notice; CMS, Centers for Medicare & Medicaid; FFS, fee-for-service; HIPAA, Health Insurance Portability and Accountability Act; MAC, Medicare
Administrative Contractors; PAD, peripheral artery disease; SET, supervised exercise therapy.
a
Each bullet provides information to consider when assessing individual patient insurance coverage for SET and when making determinations to extend visits beyond the initial 36.

Applying this to the 18-mo period for the data reported
in the previous paragraph, this suggests that about 3250
patients would have been referred over 18 mo. This is an
increase of 88% enrolled in SET compared with the initial
18 mo following CMS coverage approval. For comparison,
for CR (CPT 93797, 93798, GO422) the number of CMS
claims were 3.5 million over the same period, representing
nearly 146 000 patients.
Although the article by Divakaran et al did not report
on SET program referral rates, it is likely that this rate is
low.33 Referral rates have been a focus in the CR patient
community, and the implementation of automatic referrals
via electronic medical record when a patient is in the hospital recovering from an event or procedure has pushed this
rate to well more than 95% in many of the eligible patient
categories. Unlike those eligible for CR, most often those
with symptomatic PAD who are eligible for revascularization but not at risk of an acute limb event are not hospitalized. Thus, an automatic referral process at discharge will
not produce the same effect at improving the referral rate
as in the CR population. Thus, it is very important for SET
practitioners to consistently educate and communicate with
those treating physicians (and their staff) who regularly see
these patients in their clinics as they will be the best resource
for referrals. Although it is recognized that various practitioners and staff in an office may provide assessment and
education, the referral order must come from a physician.
Although CMS lists several deliverables that must be provided during SET (eg, 30- to 60-min sessions of therapeutic
exercise training; delivered by qualified auxiliary personnel
trained in exercise therapy for PAD; under the direct supervision of a physician or advanced practice practitioner)
that align with CR, they are silent on several other items
that are considered best practices for CR. These would
seem to reasonably apply to patients performing SET in the
CR setting and include an adequate patient-to-staff ratio
and the use of an individualized treatment plan to target
behavior change and risk factor reduction. Important areas of focus for the individualized treatment plan would
be exercise, smoking cessation, and diabetes management

with the latter two being the most important risk factors in
these patients relative to disease progression. Also note that
CMS allows advanced practice practitioners to provide the
required direct supervision for SET services, different than
the current requirement for CR, which changes in 2024
to allow advanced practice practitioners the same ability.
Regarding the patient-to-staff ratio, it is likely in many instances that this ratio is lower than the 4:1 or 5:1 often considered the norm in CR, although this can vary on the basis
of patient factors (age, frailty, ambulatory independence,
etc). Because of the specific intermittent exercise training
typically performed, there is often a need for a 1:1 staffing
ratio, particularly during the initial several SET sessions.
This is because patients need to learn the atypical exercise,
rest, and intensity progression process used in most SET
programs. Once a patient adequately learns and can apply
this process, he or she likely will not require as much staff
attention. However, some patients may never reach this level of independence.

SUMMARY
Improvement in walking performance is a universally accepted benefit of SET for those with claudication. Supervised
exercise therapy has been an insurance-reimbursed therapy
since mid-2017 in the United States. Although referral rates
are unknown, but likely low, participation rate of eligible
patients is assuredly low. Barriers include poor accessibility
to locations offering SET, transportation, and cost (eg, copay). These issues were similar in the past in CR and have,
to some degree, been overcome, although CR participation
is still low. Education of CR programs currently not offering SET and physicians who see eligible patients but do not
refer are two areas in which strategies may be focused to
help overcome barriers to participation in SET. Ongoing
research is a must as there is a paucity of SET-related presentations at national vascular surgery, vascular medicine,
and cardiology meetings. Finally, a national PAD awareness
campaign by the American Heart Association was released
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on May 25, 2022 (https://professional.heart.org/-/media/
PHD-Files-2/Science-News/p/PAD-National-Action-Plan.
pdf), and focuses on patients, providers, insurance companies, and programs that may provide SET services. The
overall goal of these activities is to enhance PAD awareness
and treatment access.

REFERENCES
1. Hageman D, Fokkenrood HJ, Gommans LN, van den Houten
MM, Teijink JA. Supervised exercise therapy versus home-based
exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev. 2018;4(4):CD005263.
doi:10.1002/14651858.CD005263.pub4.
2. Saratzis A, Paraskevopoulos I, Patel S, et al. Supervised exercise
therapy and revascularization for intermittent claudication: network meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2019;12(12):1125-1136.
3. Biswas MP, Capell WH, McDermott MM, et al. Exercise training
and revascularization in the management of symptomatic peripheral artery disease. JACC Basic Transl Sci. 2021;6(2):174-188.
4. Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/
ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of
Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines. J Am Coll Cardiol. 2017;69(11):e71-e126.
doi:10.1016/j.jacc.2016.11.007. Erratum in: J Am Coll Cardiol.
2017;69(11):1521.
5. Medicare National Coverage Determination Manual. 20.35: Supervised exercise therapy (SET) for symptomatic peripheral artery
disease (PAD). https://www.cms.gov/medicare-coverage-database/
view/ncd.aspx?ncdid=371&ncdver=1. Published May 25, 2017.
Accessed April 27, 2022.
6. Dua A, Gologorsky R, Savage D, et al. National assessment of
availability, awareness, and utilization of supervised exercise therapy for peripheral artery disease patients with intermittent claudication. J Vasc Surg. 2020;71(5):1702-1707.
7. Dieter RS, Chu WW, Pacanowski JP Jr, McBride PE, Tanke TE.
The significance of lower extremity peripheral arterial disease. Clin
Cardiol. 2002;25:3-10.
8. Gardner AW, Montgomery PS, Wang M, et al. Daily step counts in
participants with and without peripheral artery disease. J Cardiopulm Rehabil Prev. 2021;41(3):182-187.
9. Treat-Jacobson D, McDermott MM, Bronas UG, et al. Optimal
exercise programs for patients with peripheral artery disease: a
scientific statement from the American Heart Association. Circulation. 2019;139(4):e10-e33. doi:10.1161/CIR.0000000000000623.
10. Treat-Jacobson D, McDermott MM, Beckman JA, et al. Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American
Heart Association. Circulation. 2019;140(13):e700-e710.
11. Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Exercise training for claudication. N Engl J Med. 2002;347(24):1941-1951.
12. Andreozzi G, Leone A, Laudani R, Deinite G, Martini R. Acute
impairment of the endothelial function by maximal treadmill exercise in patients with intermittent claudication and its improvement
after supervised physical training. Int Angiol. 2007;26(1):12-17.
13. Duscha BD, Robbins JL, Jones WS, et al. Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol.
2011;31(11):2742-2748.
14. Hiatt W, Regensteiner J, Wolfel E, Carry M, Brass E. Effect of
exercise training on skeletal muscle histology and metabolism in
peripheral arterial disease. J Appl Physiol. 1996;81:780-788.
15. Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP.
Exercise training for intermittent claudication: does it adversely
affect biochemical markers of the exercise-induced inflammatory
response? Eur J Vasc Endovasc Surg. 1997;14(5):344-350.
16. Womack CJ, Sieminski DJ, Katzel LI, Yataco A, Gardner AW. Improved walking economy in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc. 1997;29(10):1286-1290.

www.jcrpjournal.com

17. Gardner AW, Montgomery PS, Wang M, Shen B. Association
between daily steps at moderate cadence and vascular outcomes in patients with claudication. J Cardiopulm Rehabil Prev.
2022;42(1):52-58.
18. Gardner AW, Montgomery PS, Wang M, Shen B, Zhang S, Pomilla
WA. Association between meeting physical activity time-intensity
guidelines with ambulation, quality of life, and inflammation in
claudication. J Cardiopulm Rehabil Prev. 2022. doi:10.1097/
HCR.0000000000000686.
19. Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry
versus treadmill exercise training to improve walking distance in
patients with claudication. Vasc Med. 2009;14(3):203-213.
20. Lane R, Harwood A, Watson L, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev.
2017;12(12):CD000990.
doi:10.1002/14651858.CD000990.
pub4.
21. Bronas UG, Treat-Jacobson D, Leon AS. Comparison of the effect
of upper body-ergometry aerobic training vs treadmill training on
central cardiorespiratory improvement and walking distance in patients with claudication. J Vasc Surg. 2011;53(6):1557-1564.
22. Parmenter BJ, Raymond J, Dinnen P, Singh MA. A systematic review of randomized controlled trials: walking versus alternative
exercise prescription as treatment for intermittent claudication.
Atherosclerosis. 2011;218(1):1-12.
23. Salisbury DL, Swanson K, Brown RJ, Treat-Jacobson D. Total
body recumbent stepping vs treadmill walking in supervised exercise therapy: a pilot study. Vasc Med. 2022;27(2):150-157.
24. Gardner AW, Montgomery PS, Parker DE. Physical activity is a
predictor of all-cause mortality in patients with intermittent claudication. J Vasc Surg. 2008;47(1):117-122.
25. Gardner AW, Addison O, Katzel LI, et al. Association between
physical activity and mortality in patients with claudication. Med
Sci Sports Exerc. 2021;53(4):732-739.
26. McDermott MM, Greenland P, Tian L, et al. Association of 6-minute walk performance and physical activity with incident ischemic
heart disease events and stroke in peripheral artery disease. J Am
Heart Assoc. 2015;4(7):e001846. doi:10.1161/JAHA.115.001846.
27. Piercy KL, Troiano RP, Ballard RM, et al. The physical activity
guidelines for Americans. JAMA. 2018;320(19):2020-2028.
28. Gardner AW, Parker DE, Montgomery PS, Blevins SM.
Step-monitored home exercise improves ambulation, vascular
function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc.
2014;3(5):e001107. doi:10.1161/JAHA.114.001107.
29. Salisbury DL, Whipple MO, Burt M, et al. Experience implementing supervised exercise therapy for peripheral artery disease. J Clin
Exerc Physiol. 2019;8(1):1-12. doi:10.31189/2165-6193-8.1.1.
30. Pub 100-04 Medicare Claims Processing Manual. Change Request
11022, Transmittal 4229. https://www.cms.gov/Regulations-andGuidance/Guidance/Transmittals/2019Downloads/R4229CP.pdf.
Published February 1, 2019. Accessed April 27, 2022.
31. MLN Matters 11022: SET for PAD-Clarification of Payment Rules
and Expansion of International Classification of Diseases (ICD-10)
Diagnosis Codes. https://www.cms.gov/Outreach-and-Education/
Medicare-Learning-Network-MLN/MLNMattersArticles/
downloads/MM11022.pdf. Published February 1, 2019. Accessed
April 27, 2022.
32. Vart P, Coresh J, Kwak L, Ballew SH, Heiss G, Matsushita K. Socioeconomic status and incidence of hospitalization with lower-extremity peripheral artery disease: atherosclerosis risk in communities study. J Am Heart Assoc. 2017;6(8):e004995. doi:10.1161/
JAHA.116.004995.
33. Divakaran S, Carroll BJ, Chen S, Shen C, Bonaca MP, Secemsky
EA. Supervised exercise therapy for symptomatic peripheral artery
disease among Medicare beneficiaries between 2017 and 2018: participation rates and outcomes [published online ahead of print July
23, 2021]. Circ Cardiovasc Qual Outcomes. 2021;14(8):e007953.
doi:10.1161/CIRCOUTCOMES.121.007953.
34. Centers for Medicare & Medicaid Services. License for Use of
Current Procedural Terminology, Fourth Edition (“CPT®”). Baltimore, MD: Centers for Medicare & Medicaid Services; 169 and
175. https://www.cms.gov/license/ama?file=/files/zip/2022-nprmopps-data-addendum-b-and-2-times-rule.zip. Published 2022. Accessed April 27, 2022.

Practice-Based Recommendations for SET PAD    7

Copyright © 2022 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.

